FDA Boosts Warning On Biogen's MS Drug After Rare Death
The U.S. Food and Drug Administration is adding an additional warning to Biogen Idec Inc.'s multiple sclerosis drug Tecfidera after a patient treated with the medication developed a rare brain infection...To view the full article, register now.
Already a subscriber? Click here to view full article